Placebo, intranasal

DRUG3 trials

Sponsors

Columbia University, Johns Hopkins University, Norwegian University of Science and Technology

Conditions

Drug AbuseHIV DementiaHIV-Associated Cognitive Motor ComplexMigraineOverdose

Phase 1

Intranasal Insulin for the Treatment of HAND

TerminatedNCT03081117

Johns Hopkins UniversityHIV-Associated Cognitive Motor Complex, HIV Dementia

Start: 2017-08-01End: 2020-10-16Updated: 2021-07-07

Phase 3

Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children

CompletedNCT02358681

Columbia UniversityMigraine

Start: 2015-06-16End: 2021-03-31Updated: 2022-01-12

Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital

CompletedNCT03518021

Norwegian University of Science and TechnologyDrug Abuse, Overdose

Start: 2018-05-15End: 2020-10-06Updated: 2020-10-08

Related Papers

NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use

BMJ Open2020-11-011 citations